ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2310건의 자료가 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2149 | Completed | A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients | COVID-19 | Drug: Ciclesonide Drug: Placebo |
Phase 3 | Covis Pharma S.a.r.l. | INDUSTRY | 400 | All | 12 Years ~ 100 Years | University of Buffalo, Buffalo, New York, United States |
| 2148 | Recruiting | A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above | Respiratory Syncytial Virus Infections | Biological: RSVPreF3 OA investigational vaccine Biological: COVID-19 mRNA vaccine |
Phase 3 | GlaxoSmithKline | INDUSTRY | 850 | All | 50 Years | GSK Investigational Site, Coral Gables, Florida, United States GSK Investigational Site, Savannah, Georgia, United States GSK Investigational Site, Evansville, Indiana, United States GSK Investigational Site, Omaha, Nebraska, United States GSK Investigational Site, Secaucus, New Jersey, United States GSK Investigational Site, Rochester, New York, United States GSK Investigational Site, Winston-Salem, North Carolina, United States GSK Investigational Site, North Charleston, South Carolina, United States GSK Investigational Site, Newport News, Virginia, United States GSK Investigational Site, Antwerpen, Belgium GSK Investigational Site, Edegem, Belgium GSK Investigational Site, Gent, Belgium GSK Investigational Site, Kluisbergen, Belgium GSK Investigational Site, Mechelen, Belgium GSK Investigational Site, Breda, Netherlands GSK Investigational Site, Enschede, Netherlands GSK Investigational Site, Utrecht, Netherlands GSK Investigational Site, Zutphen, Netherlands GSK Investigational Site, Boadilla del Monte, Madrid, Spain GSK Investigational Site, Barcelona, Spain GSK Investigational Site, Barcelona, Spain GSK Investigational Site, Coruna, Spain GSK Investigational Site, Madrid, Spain GSK Investigational Site, Madrid, Spain GSK Investigational Site, Majadahonda, Spain |
| 2147 | Active, not recruiting | A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults | SARS-CoV-2 | Biological: CV0701 Bivalent High dose Biological: CV0701 Bivalent Medium dose Biological: CV0701 Bivalent Low dose Biological: CV0601 Monovalent High dose Biological: Control vaccine Biological: CV0801 Monovalent |
Phase 2 | GlaxoSmithKline, CureVac | INDUSTRY | 675 | All | 18 Years | Benchmark Research - Sacramento - HyperCore - PPDS, Sacramento, California, United States Research Centers of America - CenExel - PPDS, Hollywood, Florida, United States AES - DRS - Optimal Research Illinois - Peoria, Creve Coeur, Illinois, United States Paratus Clinical Research - Canberra - PPDS, Bruce, Australian Capital Territory, Australia Paratus Clinical Research - Western Sydney - PPDS, Blacktown, New South Wales, Australia Emeritus Research - Sydney - PPDS, Botany, New South Wales, Australia Northern Beaches Clinical Research, Brookvale, New South Wales, Australia Northside Health, Coffs Harbour, New South Wales, Australia East Sydney Doctors, Darlinghurst, New South Wales, Australia Paratus Clinical Research - Central Coast - PPDS, Kanwal, New South Wales, Australia Australian Clinical Research Network, Maroubra, New South Wales, Australia Paratus Clinical Research - Brisbane Clinic - PPDS, Herston, Queensland, Australia Austrials Pty Ltd - Taringa, Taringa, Queensland, Australia AusTrials Wellers Hill, Tarragindi, Queensland, Australia Cmax - Ppds, Norwood, South Australia, Australia Emeritus Research- Melbourne PPDS, Camberwell, Victoria, Australia Hunter Diabetes Center, Merewether, Australia |
| 2146 | Completed | A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults | Covid19 | Biological: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 5mcg Biological: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 15mcg Biological: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 45mcg Other: Placebo |
Phase 1 | The University of Queensland, Syneos Health, Coalition for Epidemic Preparedness Innovations | OTHER | 216 | All | 18 Years | Nucleus Network Brisbane (Q-Pharm Pty Ltd), Herston, Queensland, Australia |
| 2145 | Completed | A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19 | COVID-19 | Drug: RESP301, a Nitric Oxide generating solution Other: Standard of Care |
Phase 3 | Thirty Respiratory Limited | INDUSTRY | 19 | All | 18 Years | Imperial College Healthcare NHS Trust, St. Mary's Hospital, London, United Kingdom Royal Preston Hospital, Preston, United Kingdom |
| 2144 | Unknown status | A Study to Assess if a Medicine Called Bamlanivimab is Safe and Effective in Reducing Hospitalization Due to COVID-19 | Covid19 | Biological: Bamlanivimab Other: Standard of Care |
Phase 4 | Fraser Health, Fraser Health Authrority Department of Evaluation and Research Services, Surrey Memorial Hospital Clinical Research Unit, Centre for Health Evaluation and Outcome Sciences, Surrey Hospital Foundation, BC Support Unit, University of British Columbia, Ministry of Health, British Columbia, Clinical Trials BC (part of the BC Academic Health Science Network) | OTHER | 576 | All | 18 Years | Fraser Health Authority, Fraser Health Region, British Columbia, Canada |
| 2143 | Completed | A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE) | COVID-19 | Drug: Gimsilumab Drug: Placebo |
Phase 2 | Kinevant Sciences GmbH, Roivant Sciences, Inc. | INDUSTRY | 227 | All | 18 Years | Banner University Medical Center, Phoenix, Arizona, United States HonorHealth John C. Lincoln Medical Center, Phoenix, Arizona, United States HonorHealth Scottsdale Osborn Medical Center, Scottsdale, Arizona, United States HonorHealth, Scottsdale, Arizona, United States HonorHealth Scottsdale Shea Medical Center, Scottsdale, Arizona, United States Banner University Medical Center, Tucson, Arizona, United States UCLA Ronald Reagan Medical Center, Los Angeles, California, United States University of Florida, Gainesville, Florida, United States Miami Cancer institute, Miami, Florida, United States Piedmont Healthcare, Atlanta, Georgia, United States Emory University School of Medicine, Atlanta, Georgia, United States NorthShore University HealthSystem, Evanston, Illinois, United States East Jefferson General Hospital, Metairie, Louisiana, United States Brigham and Women's Hospital, Boston, Massachusetts, United States Beaumont Hospital - Royal Oak, Royal Oak, Michigan, United States Jamaica Hospital Medical Center, Jamaica, New York, United States Mount Sinai Beth Israel, New York, New York, United States Mount Sinai West, New York, New York, United States Mount Sinai Morningside, New York, New York, United States Icahn School of Medicine at Mount Sinai, New York, New York, United States University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States Temple University Hospital, Philadelphia, Pennsylvania, United States Vanderbilt University Medical Center, Nashville, Tennessee, United States Baylor Jack & Jane Hamilton Heart and Vascular Hospital, Dallas, Texas, United States Baylor University Medical Center, Dallas, Texas, United States Baylor Scott & White All Saints Medical Center, Fort Worth, Texas, United States Memorial Hermann Hospital Affiliated with University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas, United States Baylor Scott & White Medical Center, Irving, Texas, United States Baylor Scott & White Heart Hospital, Plano, Texas, United States Baylor Scott & White Medical Center, Plano, Texas, United States Baylor Scott & White Medical Center, Round Rock, Texas, United States Baylor Scott & White Medical Center, Temple, Texas, United States Inova Fairfax Medical Campus, Falls Church, Virginia, United States |
